A treatment planning comparison of photon stereotactic ablative radiotherapy and proton beam therapy for the re-irradiation of pelvic cancer recurrence

MLA

R. Chuter, et al. “A Treatment Planning Comparison of Photon Stereotactic Ablative Radiotherapy and Proton Beam Therapy for the Re-Irradiation of Pelvic Cancer Recurrence.” Physics and Imaging in Radiation Oncology, vol. 21, no. 78–83, Jan. 2022, pp. 78–83. EBSCOhost, https://doi.org/10.1016/j.phro.2022.02.010.

APA

R. Chuter, E. Glassborow, R. Speight, M. Clarke, L. Murray, G. Radhakrishna, V. Lavin, L. Aspin, M Aldred, S Gregory, J. Richardson, & J. Handley. (2022). A treatment planning comparison of photon stereotactic ablative radiotherapy and proton beam therapy for the re-irradiation of pelvic cancer recurrence. Physics and Imaging in Radiation Oncology, 21(78–83), 78–83. https://doi.org/10.1016/j.phro.2022.02.010

Chicago

R. Chuter, E. Glassborow, R. Speight, M. Clarke, L. Murray, G. Radhakrishna, V. Lavin, et al. 2022. “A Treatment Planning Comparison of Photon Stereotactic Ablative Radiotherapy and Proton Beam Therapy for the Re-Irradiation of Pelvic Cancer Recurrence.” Physics and Imaging in Radiation Oncology 21 (78–83): 78–83. doi:10.1016/j.phro.2022.02.010.